Quarterly Drug Pipeline: January 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Star Tribune

Shortages in the manufacturing chain have led to label hopping and an increase in off-label use

publications The evolution of GLP-1s September 1, 2024 Prime's clinical experts share their perspectives on developing a holistic, individualized strategy to capitalize on opportunities and...

The American Journal of Managed Care (AJMC): The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still...

Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.

Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime...

CNN: At 37:03, listen to fitness expert Jillian Michaels cite Prime/Magellan Rx research on a podcast recording of a June 21 CNN broadcast